Connection

Jacobo Mintzer to Male

Back to Details
This is a "connection" page, showing publications Jacobo Mintzer has written about Male.
Jacobo Mintzer
Connection Strength
0.651
Male
  1. Dementia in the incarcerated population: a retrospective study using the South Carolina Alzheimer's disease registry, USA. Int J Prison Health. 2023 02 27; ahead-of-print(ahead-of-print).
    View in: PubMed
    Score: 0.047
  2. Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial. JAMA Neurol. 2021 11 01; 78(11):1324-1332.
    View in: PubMed
    Score: 0.043
  3. Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments. Am J Geriatr Psychiatry. 2021 01; 29(1):81-89.
    View in: PubMed
    Score: 0.039
  4. A retrospective, population-based cohort study of driving under the influence, Alzheimer's disease diagnosis, and survival. Int Psychogeriatr. 2019 04; 31(4):571-577.
    View in: PubMed
    Score: 0.035
  5. Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial. Int Psychogeriatr. 2014 Feb; 26(2):239-46.
    View in: PubMed
    Score: 0.025
  6. Establishment of a predominantly African-American cohort for the study of Alzheimer's disease: the South Carolina Alzheimer's disease clinical core. Dement Geriatr Cogn Disord. 2009; 27(4):329-36.
    View in: PubMed
    Score: 0.018
  7. Notably higher rates of vascular risk factors and dementia among African Americans in South Carolina: opportunities for public health intervention. J S C Med Assoc. 2008 Oct; 104(7):219-22.
    View in: PubMed
    Score: 0.017
  8. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses. Am J Geriatr Psychiatry. 2007 Nov; 15(11):918-31.
    View in: PubMed
    Score: 0.016
  9. Risperidone in the treatment of psychosis of Alzheimer disease: results from a prospective clinical trial. Am J Geriatr Psychiatry. 2006 Mar; 14(3):280-91.
    View in: PubMed
    Score: 0.015
  10. A comparison of extrapyramidal symptoms in older outpatients treated with quetiapine or risperidone. Curr Med Res Opin. 2004 Sep; 20(9):1483-91.
    View in: PubMed
    Score: 0.013
  11. Elderly veterans with combat-related posttraumatic stress disorder in specialty care. J Nerv Ment Dis. 2004 Jan; 192(1):75-9.
    View in: PubMed
    Score: 0.012
  12. The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure. Int J Geriatr Psychiatry. 2003 Apr; 18(4):292-7.
    View in: PubMed
    Score: 0.012
  13. Olanzapine in the treatment of anxiety symptoms due to Alzheimer's disease: a post hoc analysis. Int J Geriatr Psychiatry. 2001 Dec; 16 Suppl 1:S71-7.
    View in: PubMed
    Score: 0.011
  14. Rivastigmine Transdermal Patch Treatment for Moderate to Severe Cognitive Impairment in Veterans with Traumatic Brain Injury (RiVET Study): A Randomized Clinical Trial. J Neurotrauma. 2021 07 15; 38(14):1943-1952.
    View in: PubMed
    Score: 0.010
  15. Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial. Alzheimers Dement. 2019 11; 15(11):1427-1436.
    View in: PubMed
    Score: 0.009
  16. Fenfluramine challenge test as a marker of serotonin activity in patients with Alzheimer's dementia and agitation. Biol Psychiatry. 1998 Nov 01; 44(9):918-21.
    View in: PubMed
    Score: 0.009
  17. Sex Differences in the Neuropsychiatric Symptoms of Patients With Alzheimer's Disease. Am J Alzheimers Dis Other Demen. 2018 11; 33(7):450-457.
    View in: PubMed
    Score: 0.009
  18. Identifying persons with dementia by use of a caregiver telephone interview. Am J Geriatr Psychiatry. 1998; 6(2):176-9.
    View in: PubMed
    Score: 0.008
  19. Effectiveness of a continuum of care using brief and partial hospitalization for agitated dementia patients. Psychiatr Serv. 1997 Nov; 48(11):1435-9.
    View in: PubMed
    Score: 0.008
  20. Fluoroquinolone inhibition of clozapine metabolism. Am J Psychiatry. 1997 Jun; 154(6):881.
    View in: PubMed
    Score: 0.008
  21. Prediction of Relapse After Discontinuation of Antipsychotic Treatment in Alzheimer's Disease: The Role of Hallucinations. Am J Psychiatry. 2017 04 01; 174(4):362-369.
    View in: PubMed
    Score: 0.008
  22. Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of?Alzheimer's Disease. J Alzheimers Dis. 2016 08 10; 54(1):373-81.
    View in: PubMed
    Score: 0.007
  23. Zolpidem for the treatment of agitation in elderly demented patients. J Clin Psychiatry. 1996 Aug; 57(8):372-3.
    View in: PubMed
    Score: 0.007
  24. R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation. Br J Clin Pharmacol. 2016 09; 82(3):784-92.
    View in: PubMed
    Score: 0.007
  25. Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study. Am J Psychiatry. 2016 May 01; 173(5):473-80.
    View in: PubMed
    Score: 0.007
  26. Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial. Am J Psychiatry. 2016 May 01; 173(5):465-72.
    View in: PubMed
    Score: 0.007
  27. Cross-cultural perspectives: agitation in demented patients in the United States. Int Psychogeriatr. 1996; 8 Suppl 3:487-90; discussion 491-2.
    View in: PubMed
    Score: 0.007
  28. A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitation. J Pharmacokinet Pharmacodyn. 2016 Feb; 43(1):99-109.
    View in: PubMed
    Score: 0.007
  29. The neural correlates of anomia in the conversion from mild cognitive impairment to Alzheimer's disease. Neuroradiology. 2016 Jan; 58(1):59-67.
    View in: PubMed
    Score: 0.007
  30. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology. 2015 Oct 20; 85(16):1383-91.
    View in: PubMed
    Score: 0.007
  31. Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial. JAMA. 2015 Sep 22-29; 314(12):1242-54.
    View in: PubMed
    Score: 0.007
  32. Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial. Int Psychogeriatr. 2015 Dec; 27(12):2059-67.
    View in: PubMed
    Score: 0.007
  33. Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences. J Geriatr Psychiatry Neurol. 2016 Mar; 29(2):59-64.
    View in: PubMed
    Score: 0.007
  34. Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease. Am J Geriatr Psychiatry. 2015 Nov; 23(11):1127-33.
    View in: PubMed
    Score: 0.007
  35. Induction of salivary nerve growth factor by Yogic breathing: a randomized controlled trial. Int Psychogeriatr. 2015 Jan; 27(1):168-70.
    View in: PubMed
    Score: 0.007
  36. A new approach for the management of acute psychiatric disorders in elderly demented patients. J S C Med Assoc. 1994 Aug; 90(8):373-6.
    View in: PubMed
    Score: 0.007
  37. Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trial. PLoS One. 2014; 9(6):e98426.
    View in: PubMed
    Score: 0.006
  38. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA. 2014 Feb 19; 311(7):682-91.
    View in: PubMed
    Score: 0.006
  39. Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2. Am J Geriatr Psychiatry. 2014 Jan; 22(1):14-24.
    View in: PubMed
    Score: 0.006
  40. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA. 2014 Jan 01; 311(1):33-44.
    View in: PubMed
    Score: 0.006
  41. Behavioral Intensive Care Unit (BICU): a new concept in the management of acute agitated behavior in elderly demented patients. Gerontologist. 1993 Dec; 33(6):801-6.
    View in: PubMed
    Score: 0.006
  42. Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial. J Clin Psychiatry. 2013 Aug; 74(8):810-6.
    View in: PubMed
    Score: 0.006
  43. Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data. Alzheimers Dement. 2014 Jan; 10(1):36-44.
    View in: PubMed
    Score: 0.006
  44. Attentional functioning in patients with posttraumatic stress disorder: a preliminary study. CNS Spectr. 2013 Apr; 18(2):90-4.
    View in: PubMed
    Score: 0.006
  45. Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease. Am J Geriatr Psychiatry. 2012 Dec; 20(12):1036-44.
    View in: PubMed
    Score: 0.006
  46. Relapse risk after discontinuation of risperidone in Alzheimer's disease. N Engl J Med. 2012 Oct 18; 367(16):1497-507.
    View in: PubMed
    Score: 0.006
  47. Exploratory analysis of seven Alzheimer's disease genes: disease progression. Neurobiol Aging. 2013 Apr; 34(4):1310.e1-7.
    View in: PubMed
    Score: 0.006
  48. Subgroup analysis of US and non-US patients in a global study of high-dose donepezil (23 mg) in moderate and severe Alzheimer's disease. Am J Alzheimers Dis Other Demen. 2012 Sep; 27(6):421-32.
    View in: PubMed
    Score: 0.006
  49. Prevalence of depressive symptoms among white and African-American caregivers of demented patients. Am J Psychiatry. 1992 Apr; 149(4):575-6.
    View in: PubMed
    Score: 0.006
  50. Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A. 2012 Mar 06; 109(10):3985-90.
    View in: PubMed
    Score: 0.005
  51. Citalopram for agitation in Alzheimer's disease: design and methods. Alzheimers Dement. 2012; 8(2):121-30.
    View in: PubMed
    Score: 0.005
  52. Sertraline for the treatment of depression in Alzheimer disease: genetic influences. J Geriatr Psychiatry Neurol. 2011 Dec; 24(4):222-8.
    View in: PubMed
    Score: 0.005
  53. Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ? 2 (DIADS-2)? Int J Geriatr Psychiatry. 2011 Jun; 26(6):573-83.
    View in: PubMed
    Score: 0.005
  54. Apolipoprotein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease. Radiology. 2011 Mar; 258(3):843-52.
    View in: PubMed
    Score: 0.005
  55. Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes. Am J Geriatr Psychiatry. 2010 Apr; 18(4):332-40.
    View in: PubMed
    Score: 0.005
  56. Sertraline for the treatment of depression in Alzheimer disease. Am J Geriatr Psychiatry. 2010 Feb; 18(2):136-45.
    View in: PubMed
    Score: 0.005
  57. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials. Int J Geriatr Psychiatry. 2007 May; 22(5):475-84.
    View in: PubMed
    Score: 0.004
  58. Preliminary examination of progression of Alzheimer's disease in a rural Southern African American cohort. Arch Clin Neuropsychol. 2007 Mar; 22(3):405-14.
    View in: PubMed
    Score: 0.004
  59. Quetiapine to treat agitation in dementia: a randomized, double-blind, placebo-controlled study. Curr Alzheimer Res. 2007 Feb; 4(1):81-93.
    View in: PubMed
    Score: 0.004
  60. Design of Depression in Alzheimer's Disease Study-2. Am J Geriatr Psychiatry. 2006 Nov; 14(11):920-30.
    View in: PubMed
    Score: 0.004
  61. Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial. Am J Geriatr Psychiatry. 2006 Sep; 14(9):767-76.
    View in: PubMed
    Score: 0.004
  62. Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial. Am J Geriatr Psychiatry. 2005 Nov; 13(11):942-9.
    View in: PubMed
    Score: 0.004
  63. Clinical application of operationalized criteria for 'Depression of Alzheimer's Disease'. Int J Geriatr Psychiatry. 2005 Feb; 20(2):119-27.
    View in: PubMed
    Score: 0.003
  64. A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil. Int J Geriatr Psychiatry. 2004 Jan; 19(1):9-18.
    View in: PubMed
    Score: 0.003
  65. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004 Jan; 61(1):59-66.
    View in: PubMed
    Score: 0.003
  66. Safety and benefits of distance-adjusted prefrontal transcranial magnetic stimulation in depressed patients 55-75 years of age: a pilot study. Depress Anxiety. 2004; 19(4):249-56.
    View in: PubMed
    Score: 0.003
  67. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. Am J Psychiatry. 2003 Nov; 160(11):2003-11.
    View in: PubMed
    Score: 0.003
  68. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology. 2003 Aug 26; 61(4):479-86.
    View in: PubMed
    Score: 0.003
  69. Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia. Neuropsychopharmacology. 2002 Apr; 26(4):494-504.
    View in: PubMed
    Score: 0.003
  70. Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial. J Neurol Neurosurg Psychiatry. 2001 Nov; 71(5):589-95.
    View in: PubMed
    Score: 0.003
  71. A double-blind placebo-controlled case study of the use of donepezil to improve cognition in a schizoaffective disorder patient: functional MRI correlates. Neurocase. 2001; 7(2):105-10.
    View in: PubMed
    Score: 0.003
  72. A 24-week randomized trial of controlled-release physostigmine in patients with Alzheimer's disease. Neurology. 1999 Apr 12; 52(6):1146-52.
    View in: PubMed
    Score: 0.002
  73. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry. 1999 Feb; 60(2):107-15.
    View in: PubMed
    Score: 0.002
  74. Efficacy and adverse effects of clozapine in four elderly psychotic patients. J Clin Psychiatry. 1995 May; 56(5):180-5.
    View in: PubMed
    Score: 0.002
  75. A comparative analysis of functional status among Spanish- and English-speaking patients with dementia. J Gerontol. 1992 Nov; 47(6):P389-94.
    View in: PubMed
    Score: 0.001
  76. The occurrence of different intrusive errors in patients with Alzheimer's disease, multiple cerebral infarctions, and major depression. Brain Cogn. 1991 May; 16(1):104-17.
    View in: PubMed
    Score: 0.001
  77. Acute desensitization of lymphocyte beta-adrenergic-stimulated adenylate cyclase in old age and Alzheimer's disease. Life Sci. 1984 Oct 22; 35(17):1795-802.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.